Publication: Rabies post-exposure prophylaxis started during or after travel: A GeoSentinel analysis
dc.contributor.author | Philippe Gautret | en_US |
dc.contributor.author | Kristina M. Angelo | en_US |
dc.contributor.author | Hilmir Asgeirsson | en_US |
dc.contributor.author | David G. Lalloo | en_US |
dc.contributor.author | Marc Shaw | en_US |
dc.contributor.author | Eli Schwartz | en_US |
dc.contributor.author | Michael Libman | en_US |
dc.contributor.author | Kevin C. Kain | en_US |
dc.contributor.author | Watcharapong Piyaphanee | en_US |
dc.contributor.author | Holly Murphy | en_US |
dc.contributor.author | Karin Leder | en_US |
dc.contributor.author | Jean Vincelette | en_US |
dc.contributor.author | Mogens Jensenius | en_US |
dc.contributor.author | Jesse Waggoner | en_US |
dc.contributor.author | Daniel Leung | en_US |
dc.contributor.author | Sarah Borwein | en_US |
dc.contributor.author | Lucille Blumberg | en_US |
dc.contributor.author | Patricia Schlagenhauf | en_US |
dc.contributor.author | Elizabeth D. Barnett | en_US |
dc.contributor.author | Davidson H. Hamer | en_US |
dc.contributor.other | Oslo University Hospital | en_US |
dc.contributor.other | Aix Marseille Université | en_US |
dc.contributor.other | National Institute for Communicable Diseases | en_US |
dc.contributor.other | University of Utah, School of Medicine | en_US |
dc.contributor.other | Centers for Disease Control and Prevention | en_US |
dc.contributor.other | Liverpool School of Tropical Medicine | en_US |
dc.contributor.other | James Cook University, Australia | en_US |
dc.contributor.other | Monash University | en_US |
dc.contributor.other | Karolinska University Hospital | en_US |
dc.contributor.other | Boston University School of Public Health | en_US |
dc.contributor.other | University of Toronto | en_US |
dc.contributor.other | Mahidol University | en_US |
dc.contributor.other | University of Zurich | en_US |
dc.contributor.other | Centre Hospitalier de L'Universite de Montreal | en_US |
dc.contributor.other | Boston University School of Medicine | en_US |
dc.contributor.other | Tel Aviv University, Sackler Faculty of Medicine | en_US |
dc.contributor.other | McGill University | en_US |
dc.contributor.other | Emory University School of Medicine | en_US |
dc.contributor.other | CIWEC Travel Medicine Centre | en_US |
dc.contributor.other | Central Health Medical Practice | en_US |
dc.contributor.other | Worldwise Travellers Health Centres of New Zealand | en_US |
dc.date.accessioned | 2019-08-23T11:39:06Z | |
dc.date.available | 2019-08-23T11:39:06Z | |
dc.date.issued | 2018-11-01 | en_US |
dc.description.abstract | © 2018, Public Library of Science. All rights reserved. https://creativecommons.org/publicdomain/zero/1.0/. Background: Recent studies demonstrate that rabies post-exposure prophylaxis (RPEP) in international travelers is suboptimal, with only 5–20% of travelers receiving rabies immune globulin (RIG) in the country of exposure when indicated. We hypothesized that travelers may not be receiving RIG appropriately, and practices may vary between countries. We aim to describe the characteristics of travelers who received RIG and/or RPEP during travel. Methodology/Principal findings: We conducted a multi-center review of international travelers exposed to potentially rabid animals, collecting information on RPEP administration. Travelers who started RPEP before (Group A) and at (Group B) presentation to a GeoSentinel clinic during September 2014–July 2017 were included. We included 920 travelers who started RPEP. About two-thirds of Group A travelers with an indication for rabies immunoglobulin (RIG) did not receive it. Travelers exposed in Indonesia were less likely to receive RIG in the country of exposure (relative risk: 0.30; 95% confidence interval: 0.12–0.73; P = 0.01). Travelers exposed in Thailand [Relative risk (RR) 1.38, 95% Confidence Interval (95% CI): 1.0–1.8; P = 0.02], Sri Lanka (RR 3.99, 95% CI: 3.99–11.9; P = 0.013), and the Philippines (RR 19.95, 95% CI: 2.5–157.2; P = 0.01), were more likely to receive RIG in the country of exposure. Conclusions/Significance: This analysis highlights gaps in early delivery of RIG to travelers and identifies specific countries where travelers may be more or less likely to receive RIG. More detailed country-level information helps inform risk education of international travelers regarding appropriate rabies prevention. | en_US |
dc.identifier.citation | PLoS Neglected Tropical Diseases. Vol.12, No.11 (2018) | en_US |
dc.identifier.doi | 10.1371/journal.pntd.0006951 | en_US |
dc.identifier.issn | 19352735 | en_US |
dc.identifier.issn | 19352727 | en_US |
dc.identifier.other | 2-s2.0-85057273821 | en_US |
dc.identifier.uri | https://repository.li.mahidol.ac.th/handle/20.500.14594/46235 | |
dc.rights | Mahidol University | en_US |
dc.rights.holder | SCOPUS | en_US |
dc.source.uri | https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85057273821&origin=inward | en_US |
dc.subject | Medicine | en_US |
dc.title | Rabies post-exposure prophylaxis started during or after travel: A GeoSentinel analysis | en_US |
dc.type | Article | en_US |
dspace.entity.type | Publication | |
mu.datasource.scopus | https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85057273821&origin=inward | en_US |